PMID: 8605273Jan 1, 1996Paper

Hematopoietic growth factors and treatment of testicular cancer: biological interactions, routine use and dose-intensive chemotherapy

Annals of Hematology
C BokemeyerH J Schmoll

Abstract

With the use of aggressive cis-platinum-based combination chemotherapy the majority of patients with metastatic testicular cancer will be cured. Hematopoietic growth factors (HGFs), particularly G- and GM-CSF, have been investigated for the treatment of testicular cancer in order to (a) ameliorate chemotherapy-induced myelosuppression, (b) increase the dose intensity of treatment, or (c) generate peripheral blood stem cells (PBSC) as hematopoietic support for mega-dose chemotherapy. Results from in vitro and animal models have excluded a significant influence of both factors, G-CSF and GM-CSF, on tumor growth and response to cytotoxic treatment. For the group of 'good-risk' patients with metastatic testicular cancer, 85-90% of whom will reach long-term survival, the incidence of granulocytopenic infections after standard chemotherapy regimens appears to be lower than 20%. The prophylactic use of HGFs for these patients is not routinely recommended but may be considered in case of an increased risk for infections. For 'poor risk' patients, who will achieve 50% survival following standard chemotherapy, different attempts of treatment intensification have been investigated. The use of aggressive multidrug regimens is associated wi...Continue Reading

References

Dec 1, 1992·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S RodenhuisD J Richel
Nov 18, 1992·Journal of the National Cancer Institute·R J Motzer, G J Bosl
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D J Husband, J A Green
Jul 2, 1992·The New England Journal of Medicine·G J Lieschke, A W Burgess
Apr 1, 1992·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G Daugaard, M Rørth
Sep 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A HarstrickC Bokemeyer
Jan 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A J WozniakB A Blumenstein
Nov 1, 1990·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L M JostR A Stahel
Mar 1, 1991·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A HarstrickF Natt
Mar 1, 1991·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C R LewisB Cantwell
Jul 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C R NicholsL H Einhorn
Nov 1, 1991·Japanese Journal of Cancer Research : Gann·G CimoliM Venturini
Jan 1, 1991·American Journal of Clinical Oncology·L KanzR Mertelsmann
Jan 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A D EliasK H Antman
May 17, 1990·The New England Journal of Medicine·C R NicholsG Tricot
Mar 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R BirchF A Greco
Jun 4, 1987·The New England Journal of Medicine·S D WilliamsP J Loehrer
Mar 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L H EinhornF A Greco
Mar 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C J LogothetisA C von Eschenbach
Apr 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P J LoehrerS D Williams
Apr 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S N WolffF A Greco
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E Diaz-Rubio, E Adrover
Apr 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G SpitzerW McIntyre
Jan 1, 1994·World Journal of Urology·J BeyerW Siegert
Feb 1, 1995·British Journal of Urology·M Honnens de LichtenbergH Rolff
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M A Boogaerts
Aug 1, 1994·Current Biology : CB·G PanganibanS B Carroll
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C BokemeyerW Siegert
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C BokemeyerA Harstrick

❮ Previous
Next ❯

Citations

Feb 15, 2001·Computers in Biology and Medicine·D Barbolosi, A Iliadis
Jun 11, 2010·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Emma J AlexanderAlan Horwich
Sep 18, 2007·Der Urologe. Ausg. A·F vom DorpH Rübben
Jun 9, 2005·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Attila TorkosJózsef Jóri
Apr 19, 2011·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Christopher KimYawei Zhang
Mar 16, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Sean D SullivanJeannine S McCune
Jun 6, 2008·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Haitham W TuffahaLuna Zaru
Mar 16, 2011·Nature Reviews. Urology·Chunkit Fung, David J Vaughn
Aug 21, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H J SchmollUNKNOWN European Germ Cell Cancer Consensus Group
Aug 7, 2010·Journal of the Chinese Medical Association : JCMA·Chung-King Lin, Han-Ting Liu
Aug 9, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hrishikesh M MehtaSeth J Corey
Sep 3, 2016·Molecular and Clinical Oncology·Thierry GilAlexandre Peltier
Oct 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H OzerUNKNOWN American Society of Clinical Oncology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.